NASDAQ:GILD - Gilead Sciences News Headlines

Sign in or create an account to add this stock to your watchlist.
$77.12 -0.08 (-0.10 %)
(As of 07/18/2018 04:00 PM ET)
Previous Close$77.10
Today's Range$76.83 - $77.78
52-Week Range$64.27 - $89.54
Volume518,369 shs
Average Volume6.04 million shs
Market Capitalization$100.46 billion
P/E Ratio9.00
Dividend Yield2.95%
Beta1.12

Headlines

Gilead Sciences (NASDAQ GILD) News Headlines

Source:
DateHeadline
Cramer's charts suggest big-name biotech stocks Gilead and Celgene have more room to runCramer's charts suggest big-name biotech stocks Gilead and Celgene have more room to run
finance.yahoo.com - July 18 at 3:11 PM
Leerink Swann Comments on Gilead Sciences, Inc.s Q2 2018 Earnings (GILD)Leerink Swann Comments on Gilead Sciences, Inc.'s Q2 2018 Earnings (GILD)
www.americanbankingnews.com - July 18 at 7:42 AM
Cramers charts suggest big-name biotech stocks Gilead and Celgene have more room to runCramer's charts suggest big-name biotech stocks Gilead and Celgene have more room to run
finance.yahoo.com - July 18 at 5:04 AM
Gileads HIV Franchise Under Assault As It Stares Down Paradigm-Changing DrugGilead's HIV Franchise Under Assault As It Stares Down Paradigm-Changing Drug
seekingalpha.com - July 17 at 3:09 PM
Your 52 Top Yield, Upside, And Net Gain Nasdaq Stocks For JulyYour 52 Top Yield, Upside, And Net Gain Nasdaq Stocks For July
seekingalpha.com - July 17 at 5:13 AM
Gilead Sciences (GILD) to Release Earnings on TuesdayGilead Sciences (GILD) to Release Earnings on Tuesday
www.americanbankingnews.com - July 17 at 3:46 AM
Gilead Sciences, Inc. (GILD) Short Interest UpdateGilead Sciences, Inc. (GILD) Short Interest Update
www.americanbankingnews.com - July 14 at 4:06 PM
Gileads Hot Stock May Have Further to RiseGilead's Hot Stock May Have Further to Rise
finance.yahoo.com - July 14 at 3:20 PM
Gilead Sciences to Release Second Quarter 2018 Financial Results on Wednesday, July 25, 2018Gilead Sciences to Release Second Quarter 2018 Financial Results on Wednesday, July 25, 2018
finance.yahoo.com - July 14 at 3:20 PM
3 Biotech Stocks With Big News Coming in NASH3 Biotech Stocks With Big News Coming in NASH
finance.yahoo.com - July 14 at 3:20 PM
Gilead: Cheap Valuation For Great PipelineGilead: Cheap Valuation For Great Pipeline
seekingalpha.com - July 12 at 3:06 PM
If You're Thinking About Buying Gilead Sciences Stock, Now's the Time to Do ItIf You're Thinking About Buying Gilead Sciences Stock, Now's the Time to Do It
finance.yahoo.com - July 12 at 8:49 AM
If Youre Thinking About Buying Gilead Sciences Stock, Nows the Time to Do ItIf You're Thinking About Buying Gilead Sciences Stock, Now's the Time to Do It
www.fool.com - July 12 at 6:31 AM
Equities Analysts Issue Forecasts for Gilead Sciences, Inc.s Q2 2018 Earnings (GILD)Equities Analysts Issue Forecasts for Gilead Sciences, Inc.'s Q2 2018 Earnings (GILD)
www.americanbankingnews.com - July 11 at 9:05 AM
The Zacks Analyst Blog Highlights: Mastercard, Gilead, Goldman Sachs, PepsiCo and AetnaThe Zacks Analyst Blog Highlights: Mastercard, Gilead, Goldman Sachs, PepsiCo and Aetna
finance.yahoo.com - July 10 at 3:12 PM
Trade of the Day: Gilead Sciences (GILD)Trade of the Day: Gilead Sciences (GILD)
investorplace.com - July 10 at 9:48 AM
Bullish Two Hundred Day Moving Average Cross - GILDBullish Two Hundred Day Moving Average Cross - GILD
www.nasdaq.com - July 10 at 5:06 AM
Michael Amoroso to Join Kite as Senior Vice President and Head of Worldwide Commercial, Cell TherapyMichael Amoroso to Join Kite as Senior Vice President and Head of Worldwide Commercial, Cell Therapy
finance.yahoo.com - July 10 at 5:06 AM
Gilead Sciences Near-Term Data Release For Rheumatoid Arthritis Is An Important EventGilead Sciences Near-Term Data Release For Rheumatoid Arthritis Is An Important Event
seekingalpha.com - July 9 at 3:11 PM
Gilead Q2 Results Could Initiate A RallyGilead Q2 Results Could Initiate A Rally
seekingalpha.com - July 9 at 3:11 PM
Top Research Reports for Mastercard, Gilead & Goldman SachsTop Research Reports for Mastercard, Gilead & Goldman Sachs
finance.yahoo.com - July 9 at 3:11 PM
Zacks: Brokerages Anticipate Gilead Sciences, Inc. (GILD) Will Announce Quarterly Sales of $5.17 BillionZacks: Brokerages Anticipate Gilead Sciences, Inc. (GILD) Will Announce Quarterly Sales of $5.17 Billion
www.americanbankingnews.com - July 8 at 2:58 AM
Noteworthy Friday Option Activity: GILD, OMC, ADSKNoteworthy Friday Option Activity: GILD, OMC, ADSK
www.nasdaq.com - July 6 at 3:08 PM
Gilead Sciences Is Displaying a Bullish Long-Term PatternGilead Sciences Is Displaying a Bullish Long-Term Pattern
finance.yahoo.com - July 6 at 3:08 PM
Biotech Stocks Rally on Biogens Landmark TestBiotech Stocks Rally on Biogen's Landmark Test
finance.yahoo.com - July 6 at 3:08 PM
7 Stocks That Can Lead The Market Longterm7 Stocks That Can Lead The Market Longterm
finance.yahoo.com - July 6 at 3:08 PM
Gilead Sciences, Inc. (GILD) Expected to Post Earnings of $1.53 Per ShareGilead Sciences, Inc. (GILD) Expected to Post Earnings of $1.53 Per Share
www.americanbankingnews.com - July 6 at 2:08 PM
Biotech Stock Roundup: GILD's Positive CHMP Nod, Regulatory Updates & MoreBiotech Stock Roundup: GILD's Positive CHMP Nod, Regulatory Updates & More
finance.yahoo.com - July 6 at 5:21 AM
Gilead Sciences, Inc. (GILD) Director John C. Martin Sells 50,000 SharesGilead Sciences, Inc. (GILD) Director John C. Martin Sells 50,000 Shares
www.americanbankingnews.com - July 5 at 9:14 PM
Gilead: A Top Biotech Pick for a TurnaroundGilead: A Top Biotech Pick for a Turnaround
finance.yahoo.com - July 5 at 3:15 PM
Is Gilead Sciences a Great Stock for Value Investors?Is Gilead Sciences a Great Stock for Value Investors?
www.zacks.com - July 3 at 9:02 AM
Gileads (GILD) CAR T Therapy Gets Positive CHMP OpinionGilead's (GILD) CAR T Therapy Gets Positive CHMP Opinion
finance.yahoo.com - July 2 at 4:39 PM
Gilead's (GILD) CAR T Therapy Gets Positive CHMP OpinionGilead's (GILD) CAR T Therapy Gets Positive CHMP Opinion
finance.yahoo.com - July 2 at 4:39 PM
Rival Novartis, Gilead CAR-T therapies win European panel recommendationRival Novartis, Gilead CAR-T therapies win European panel recommendation
finance.yahoo.com - June 30 at 10:41 AM
Rival Novartis, Gilead CAR-T therapies win CHMP recommendationsRival Novartis, Gilead CAR-T therapies win CHMP recommendations
seekingalpha.com - June 30 at 10:41 AM
Head-To-Head Analysis: Gilead Sciences (GILD) versus Genocea Biosciences (GNCA)Head-To-Head Analysis: Gilead Sciences (GILD) versus Genocea Biosciences (GNCA)
www.americanbankingnews.com - June 29 at 6:30 PM
5 Undervalued Large-Cap Stocks For Value Investors - June 20185 Undervalued Large-Cap Stocks For Value Investors - June 2018
seekingalpha.com - June 28 at 3:17 PM
Raymond James initiates Gilead at 35% upsideRaymond James initiates Gilead at 35% upside
seekingalpha.com - June 28 at 3:17 PM
Gilead Sciences (GILD) Now Covered by Raymond JamesGilead Sciences (GILD) Now Covered by Raymond James
www.americanbankingnews.com - June 28 at 12:19 PM
Here Are 43 Of 84 Safer Healthcare High Yield Dividend Equities For JuneHere Are 43 Of 84 'Safer' Healthcare High Yield Dividend Equities For June
seekingalpha.com - June 27 at 5:52 AM
Gileads (GILD) Biktarvy Gets EC Nod for HIV- 1 InfectionGilead's (GILD) Biktarvy Gets EC Nod for HIV- 1 Infection
finance.yahoo.com - June 26 at 3:16 PM
Gilead's (GILD) Biktarvy Gets EC Nod for HIV- 1 InfectionGilead's (GILD) Biktarvy Gets EC Nod for HIV- 1 Infection
finance.yahoo.com - June 26 at 3:16 PM
Gilead Sciences (GILD) Announces EC Granted Marketing Authorization for its Biktarvy for Treatment of HIV-1 InfectionGilead Sciences (GILD) Announces EC Granted Marketing Authorization for its Biktarvy for Treatment of HIV-1 Infection
www.streetinsider.com - June 26 at 5:16 AM
EC Grants Authorization For Gileads Biktarvy For Treatment Of HIV-1 InfectionEC Grants Authorization For Gilead's Biktarvy For Treatment Of HIV-1 Infection
www.nasdaq.com - June 25 at 3:13 PM
European Commission Grants Marketing Authorization for Gilead’s Biktarvy® (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for the Treatment of HIV-1 InfectionEuropean Commission Grants Marketing Authorization for Gilead’s Biktarvy® (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for the Treatment of HIV-1 Infection
finance.yahoo.com - June 25 at 3:13 PM
Gilead Sciences, Inc. (GILD) Receives Consensus Recommendation of "Buy" from AnalystsGilead Sciences, Inc. (GILD) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - June 25 at 11:37 AM
Cramers lightning round: I dont like Snaps ownership structureCramer's lightning round: I don't like Snap's ownership structure
finance.yahoo.com - June 23 at 6:08 AM
3 Big Biotechs That Can Beat the Market3 Big Biotechs That Can Beat the Market
finance.yahoo.com - June 21 at 3:21 PM
Gilead Sciences Inc (NASDAQ:GILD): Should The Recent Earnings Drop Worry You?Gilead Sciences Inc (NASDAQ:GILD): Should The Recent Earnings Drop Worry You?
finance.yahoo.com - June 21 at 3:21 PM
Gilead Sciences, Inc. (GILD) Expected to Announce Quarterly Sales of $5.15 BillionGilead Sciences, Inc. (GILD) Expected to Announce Quarterly Sales of $5.15 Billion
www.americanbankingnews.com - June 21 at 4:10 AM
This page was last updated on 7/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.